Cohen Klingenstein LLC decreased its position in shares of The Allstate Co. (NYSE:ALL - Free Report) by 20.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 24,811 shares of the insurance provider's stock after selling 6,250 shares during the period. Cohen Klingenstein LLC's holdings in Allstate were worth $4,783,000 as of its most recent SEC filing.
Several other large investors have also modified their holdings of ALL. SPC Financial Inc. raised its holdings in Allstate by 3.6% during the third quarter. SPC Financial Inc. now owns 1,564 shares of the insurance provider's stock worth $297,000 after purchasing an additional 54 shares in the last quarter. Lake Street Advisors Group LLC lifted its holdings in shares of Allstate by 1.8% in the 3rd quarter. Lake Street Advisors Group LLC now owns 3,129 shares of the insurance provider's stock valued at $596,000 after buying an additional 54 shares during the period. Abacus Planning Group Inc. boosted its stake in shares of Allstate by 2.4% in the third quarter. Abacus Planning Group Inc. now owns 2,416 shares of the insurance provider's stock valued at $458,000 after buying an additional 56 shares in the last quarter. Chicago Partners Investment Group LLC raised its position in Allstate by 1.3% in the third quarter. Chicago Partners Investment Group LLC now owns 4,630 shares of the insurance provider's stock worth $893,000 after acquiring an additional 59 shares in the last quarter. Finally, Carmichael Hill & Associates Inc. boosted its position in shares of Allstate by 15.0% during the 3rd quarter. Carmichael Hill & Associates Inc. now owns 460 shares of the insurance provider's stock worth $87,000 after purchasing an additional 60 shares in the last quarter. 76.47% of the stock is owned by institutional investors and hedge funds.
Allstate Trading Down 1.2 %
Allstate stock traded down $2.25 during trading on Friday, reaching $188.85. The company had a trading volume of 1,518,986 shares, compared to its average volume of 1,271,858. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.40 and a current ratio of 0.40. The firm has a market capitalization of $50.01 billion, a price-to-earnings ratio of 12.23, a PEG ratio of 1.35 and a beta of 0.52. The Allstate Co. has a 12-month low of $150.17 and a 12-month high of $209.88. The stock's 50 day moving average price is $195.73 and its two-hundred day moving average price is $186.50.
Allstate (NYSE:ALL - Get Free Report) last released its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $3.91 EPS for the quarter, topping analysts' consensus estimates of $2.20 by $1.71. Allstate had a return on equity of 26.67% and a net margin of 6.77%. The business had revenue of $16.63 billion during the quarter, compared to the consensus estimate of $14.57 billion. During the same period in the prior year, the firm posted $0.81 EPS. The business's revenue for the quarter was up 14.7% on a year-over-year basis. As a group, equities analysts expect that The Allstate Co. will post 16.45 earnings per share for the current fiscal year.
Allstate Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Thursday, January 2nd. Shareholders of record on Friday, November 29th were given a dividend of $0.92 per share. The ex-dividend date of this dividend was Friday, November 29th. This represents a $3.68 dividend on an annualized basis and a yield of 1.95%. Allstate's dividend payout ratio (DPR) is 23.83%.
Analysts Set New Price Targets
Several brokerages recently commented on ALL. JPMorgan Chase & Co. raised their price objective on shares of Allstate from $205.00 to $207.00 and gave the company an "overweight" rating in a research note on Thursday, October 10th. Barclays reduced their price objective on Allstate from $187.00 to $183.00 and set an "underweight" rating for the company in a report on Monday, January 6th. Wells Fargo & Company upped their target price on Allstate from $186.00 to $187.00 and gave the company an "equal weight" rating in a report on Tuesday, January 14th. Evercore ISI raised Allstate from an "in-line" rating to an "outperform" rating in a research note on Wednesday, January 8th. Finally, Piper Sandler raised their target price on shares of Allstate from $206.00 to $244.00 and gave the company an "overweight" rating in a report on Tuesday, November 26th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating, fourteen have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $218.13.
View Our Latest Stock Report on Allstate
About Allstate
(
Free Report)
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
Featured Articles
Before you consider Allstate, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Allstate wasn't on the list.
While Allstate currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.